Raptamer Therapeutics
PrivateLast Round
Grant
Aug 11, 2021
Total Funding Raised
$3.72M
Company Overview
Raptamer Therapeutics is a biotechnology company that specializes in the development of next-generation, high-quality DNA molecules, called Raptamers, for use as therapeutic, diagnostic, or research agents.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raptamer Therapeutics Comparables
Compare Raptamer Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Base Pair Biotechnologies | 86% | |
| Aptagen, LLC | 84% | |
| TAGCyx Biotechnologies Inc. | 83% |
Raptamer Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 11, 2021 | ||||
| Grant | Jun 1, 2011 |
Raptamer Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fannin Innovation Studio | M&A |
| Bill & Melinda Gates Foundation | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2021
$2M grant received from the National Institutes of Health.
- Jun 1, 2011
Received $1.7M from the Bill & Melinda Gates Foundation.
Raptamer Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Raptamer Therapeutics's valuation, stock price, and market status.
Is Raptamer Therapeutics a public or private company?
Raptamer Therapeutics is a private company.
What is the current stock price of Raptamer Therapeutics?
Raptamer Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Raptamer Therapeutics worth (valuation)?
Valuation information for Raptamer Therapeutics is not publicly available.
Can I buy Raptamer Therapeutics stock?
Raptamer Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Raptamer Therapeutics's last funding round?
Funding round information for Raptamer Therapeutics is not publicly available.
Who are the main investors in Raptamer Therapeutics?
Investor information for Raptamer Therapeutics is not publicly disclosed.
Will Raptamer Therapeutics IPO soon?
No public IPO plans have been announced for Raptamer Therapeutics.
How can I track Raptamer Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Raptamer Therapeutics's secondary market activity and sign up for updates.